[Form 4] Labcorp Holdings Inc. Insider Trading Activity

Rhea-AI Filing Summary

Sandra D. van der Vaart, identified as EVP, Chief Legal Officer of Labcorp Holdings Inc. (LH), reported offsetting option exercise and share sale transactions dated 08/13/2025. She exercised 3,903 non-qualified stock options with an exercise price of $131.43 per share, resulting in the acquisition of 3,903 common shares. On the same date she sold 3,903 common shares at a reported price of $271.4249 per share. The filing shows 6,176.6691 shares beneficially owned after the acquisition line and 2,273.6691 shares after the sale line. The options were granted under the company omnibus plan, vesting began 02/12/2020 and are exercisable through 02/11/2029. An additional 30.1294 shares were included from the employee stock purchase plan.

Positive

• Exercise of 3,903 non-qualified options at a stated exercise price of $131.43, demonstrating use of vested equity awards
• Disclosure includes ESPP share credit of 30.1294 shares, reflecting participation in the employee purchase plan
• Form is signed by the reporting person, indicating a complete Section 16 filing

Negative

• Sale of 3,903 shares on the same date reduced the reporting person’s beneficial holdings to 2,273.6691 shares as shown
• No new grants or strategic rationale provided in the filing beyond automated adjustment language related to the spin-off

Insights

Securities Analyst

TL;DR: Executive exercised options and immediately sold an equal number of shares, leaving a reduced net holding.

The report documents a routine exercise of non-qualified stock options followed by an immediate sale of the same number of shares, both on 08/13/2025. The exercise price is stated at $131.43 and the sale price at $271.4249, with the option originally granted under the company omnibus incentive plan and fully exercisable. From an investor-monitoring perspective, this is a standard liquidity-management transaction by an insider and does not by itself disclose strategic corporate changes or material new information about Labcorp's operations or financial condition.

Corporate Governance Expert

TL;DR: Filing reflects compliance with Section 16 reporting and documents an equity award adjustment tied to a prior spin-off.

The filing includes an explicit adjustment note stating amounts were automatically adjusted due to the Fortrea spin-off, calculated per an Employee Matters Agreement. It also discloses inclusion of 30.1294 ESPP shares. The form is signed and dated by the reporting person, evidencing adherence to reporting formalities. There are no disclosures of departures, new grants beyond the adjusted option, or other governance actions in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

van der Vaart Sandra D

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/13/2025		M		3,903	A	$131.43	6,176.6691(1)	D
Common Stock	08/13/2025		S		3,903	D	$271.4249	2,273.6691(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-qualified Stock Options(2)	$131.43(3)	08/13/2025		M			3,903(3)	02/12/2020(4)	02/11/2029	Common Stock	3,903	$0	0	D

Explanation of Responses:

1. Amount includes 30.1294 shares acquired on June 30, 2025 under the Labcorp Holdings Inc. Amended and Restated 2016 Employee Stock Purchase Plan.

2. Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.

3. Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("Labcorp"), calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea.

4. The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.

	/s/ Sandra D. van der Vaart	08/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Sandra D. van der Vaart report on the Form 4 for Labcorp (LH)?

She reported the exercise of 3,903 non-qualified stock options at $131.43 per share and the sale of 3,903 common shares at $271.4249 per share, both dated 08/13/2025.

How many Labcorp (LH) shares does the filing show were beneficially owned after the transactions?

The filing lists 6,176.6691 shares following the acquisition line and 2,273.6691 shares following the sale line.

Were the exercised options fully vested and what are their key dates?

Yes; the options were granted under the omnibus plan, vested in three installments beginning 02/12/2020 and are exercisable with an expiration date of 02/11/2029.

Did the Form 4 mention any adjustments related to corporate actions?

Yes; amounts were automatically adjusted due to the spin-off of Fortrea Holdings Inc., calculated per the Employee Matters Agreement.

Did the filing include shares from an employee purchase plan?

Yes; it includes 30.1294 shares acquired on 06/30/2025 under the Labcorp Amended and Restated 2016 Employee Stock Purchase Plan.